SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4051<i>I think that the market has this wrong so far, possibility because someDewDiligence_on_SI-3/28/2007
4050GS on pfizer results "...Pfizer Inc. EPS (FY Dec) 2007E $2.11, 2008E $2.30bob zagorin-3/28/2007
4049fwiw, after spending many hours reading and listening to everything i can find obob zagorin-3/28/2007
4048drugresearcher.com drugresearcher.com Isis cholesterol drug makes sense By Mibob zagorin-3/28/2007
4047Reuters CORRECTION - Isis drug cuts cholesterol 47 pct on top of statins yahoo.rMLD38-3/27/2007
4046Isis cholesterol drug shows promise in tests (with quotes from McCamant) By: BRbob zagorin-3/27/2007
4045just spent about an hour and a half listening to the presentation and slides. thbob zagorin-3/27/2007
4044ISIS 301012 Significantly Reduces LDL-C and Other Harmful Lipids and Is Well Tolbob zagorin-3/27/2007
4043<i>this from reuters although i can't quite figure out the headline<DewDiligence_on_SI-3/27/2007
4042live video news conference before the open tuesday. videonewswire.combob zagorin-3/27/2007
4041 Isis: Phase II Trial Results Show ISIS 301012 Effective DOW JONES NEWSWIRES Mabob zagorin-3/26/2007
4040this from reuters although i can't quite figure out the headline.. Isis higbob zagorin-3/26/2007
4039Study Presented at ACC Shows Treatment With ISIS 301012 Added to Statins for Onlbob zagorin-3/26/2007
4038forbes.. Bad Cholesterol's Comeback Matthew Herper and Robert Langreth 03.2bob zagorin-3/26/2007
4037but no comments on the blood pressure problem. UPDATE 1-Pfizer HDL drug fails tbob zagorin-3/26/2007
4036thanks. will do... did you see he comments by dr. nissen on the pfizer results. bob zagorin-3/26/2007
4035>>New Data Presented at ACC Show ISIS 301012 Monotherapy Reduces apoB to Utuck-3/26/2007
4034hypercholesterolemia study biz.yahoo.com "...According to Evan Stein, M.D.bob zagorin-3/26/2007
4033Isis Pharmaceuticals "buy," target price raised Monday, March 26, 200bob zagorin-3/26/2007
4032excellent! biz.yahoo.combob zagorin-3/25/2007
4031deletedbob zagorin-3/24/2007
4030Steve Part of this lies in the requirements by insurers and the medical communiMJ-3/24/2007
4029<i>Seems like we are missing something in the diagnostic stage.</i> Steve Lokness-3/24/2007
4028Bob The silencing of genes and identification of genes truly sounds great. WheMJ-3/24/2007
4027and another backgrounder from feb. (seeking alpha) Eye on Alnylam: Silencing thbob zagorin-3/23/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):